scholarly journals Ways to Improve Medication Adherence in Chronic Disease Patients – A Review

2021 ◽  
Vol 10 (36) ◽  
pp. 3171-3177
Author(s):  
Juhi Singh ◽  
Md Shamshir Alam ◽  
Anuj Malik ◽  
Shubham Singh Tyagi ◽  
Mohd Tousib ◽  
...  

Adherence has been defined as the “voluntary, active, and collaborative involvement of the patients in mutually acceptable courses of behaviour to produce desired therapeutic effects”. Medication adherence generally illustrates the term as to whether the patients take their medicines as per prescription instruction and either they keep on to take a prescribed medication. Medication adherence performance has thus been classified into two head conceptions, namely, adherence and persistence. Whilst theoretically similar, adherence refers to concentration of drug utilization for the duration of the ongoing treatment, whereas persistence refers to the general interval of drug therapy. Improving prescription adherence may impact the well-being of the populace than the revelation of any new treatment. Indian patients are not adherent to their medication half the time, mainly due to lack of proper education and patient counselling. Albeit most doctors do not accept adherence basically because of the absence of access or neglect, and no adherence can frequently be a purposeful decision made by the Indian patients. Persistent covering of their medicine taking conduct is regularly persuaded by feelings with respect to both supplier and the patient, prompting possible desperate outcomes. On time medicine taking behaviour of the patients have great impact on the health of people than the need for new treatment option. KEY WORDS Medication Adherence, Drug Therapy, Prescription, Wellbeing, Compliance, Chronic Disease

2020 ◽  
Vol 11 ◽  
Author(s):  
Hai-Yan Xu ◽  
Yong-Ju Yu ◽  
Qian-Hui Zhang ◽  
Hou-Yuan Hu ◽  
Min Li

Over the past half-century, medical research on cardiovascular disease (CVD) has achieved a great deal; however, medication adherence is unsatisfactory. Nearly 50% of patients do not follow prescriptions when taking medications, which limits the ability to maximize their therapeutic effects and results in adverse clinical outcomes and high healthcare costs. Furthermore, the effects of medication adherence interventions are disappointing, and tailored interventions have been proposed as an appropriate way to improve medication adherence. To rethink and reconstruct methods of improving medication adherence for CVD, the literature on tailored interventions for medication adherence focusing on CVD within the last 5 years is retrieved and reviewed. Focusing on identifying nonadherent patients, detecting barriers to medication adherence, delivering clinical interventions, and constructing theories, this article reviews the present state of tailored interventions for medication adherence in CVD and also rethinks the present difficulties and suggests avenues for future development.


Author(s):  
PRATHYUSHA RANI T ◽  
PRASHANTHI B ◽  
AYESHA AMREEN FATHIMA ◽  
AYESHA FIRDOSE ◽  
SARA NASER ◽  
...  

Objective: This study was conducted to determine the adherence of medications among type 2 diabetes mellitus (DM) patients. To evaluate adherence to therapy and study factors associated with non-adherence and adherence in patients with type II DM. Methods: A cross-sectional, observational study was conducted for 6 months in three hospitals. A total of 200 type II diabetic patients, who were on anti-diabetic drug therapy for at least 6 months, were enrolled. Blood glucose was measured and details of drug therapy were noted. Medication adherence was assessed using the Morisky Medication Adherence Scale and adherence scores were calculated. Results: Only 15% had high medication adherence, while 24% had moderate and 61% had low medication adherence. Only 30% were having optimally controlled glycemic levels, whereas 70% were having uncontrolled glycemic levels. Medication adherence scores were lower (reflecting lower adherence) in type II patients with uncontrolled glycemic levels than those having optimally controlled glycemic levels, but this difference was not statistically significant. Conclusion: Overall, medication adherence was low in type II diabetic patients. The study shows that to improve medication adherence, better counseling and health education of patients are required. Although several patients were adherent to therapy, adherent patients are more preferably to achieve glycemic control than nonadherent patients. Greater efforts are needed to facilitate diabetes self-management behaviors to improve patient outcomes.


Author(s):  
Mohammed Safeer V S ◽  
Dr M Umesh

According to various studies conducted on HRQoL it was found that patient counselling provided by a pharmacist play an appreciable role in improving the HRQoL of the patients. Patient counselling plays a pivotal role in improving patient understanding about the disease and medications. Patient counselling can be provided through various mediums such as face-to-face counselling, patient information leaflets. The HRQoL of the patients can be assessed using various questionnaires available. The aim of the study is to assess influence of pharmacist provided counselling on improving the Health related quality of life (HRQoL) in patients with chronic diseases. Over a period of nine months, a prospective interventional study was held in the department of General Medicine JSS Hospital, Mysuru. Ethics committee approval was obtained for this study. Patients that fulfilled the requirements were included in the research and were educated about the disease, medications, importance of medication adherence and lifestyle modifications. All the necessary data have been gathered and recorded. The HRQoL was determined before and after educating using HRQoL (SF-20) questionnaire respectively. Paired student t-test had been used to compare the pre and post HRQoL scores. Out of 227 subjects admitted in the study, 66(29%) had Diabetes Mellitus, 55(24%) had been diagnosed with hypertension, 52(23%) had been diagnosed with stroke and 54(24%) were diagnosed with bronchial asthma. All the study participants with different chronic disease were given with the HRQoL questionnaire before education (baseline) and after education (follow up). There was a significant increase in the patients’ HRQoL scores after education as p-value which has been calculated was <0.001. Educating or counselling the patients regarding disease, medication and medication adherence helps in improving the Health related quality of life (HRQoL) in chronic disease patients.


2017 ◽  
Vol 6 (1) ◽  
pp. 63 ◽  
Author(s):  
AhmadAli Eslami ◽  
SeydeShahrbanoo Daniali ◽  
FiroozeMostafavi Darani ◽  
Mohammad Mazaheri

Sign in / Sign up

Export Citation Format

Share Document